Lv2
180 积分 2023-08-31 加入
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
2天前
已完结
Deciphering differential response to NB‐UVB: The hair matters
4天前
已完结
Why Anti– IL ‐17 Therapy Fails: The Role of Autonomous IL ‐ 17R Signaling in Autoimmune Inflammation
11天前
已完结
Why Anti– IL ‐17 Therapy Fails: The Role of Autonomous IL ‐ 17R Signaling in Autoimmune Inflammation
11天前
已关闭
Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research
23天前
已完结
The Effects of a Peer-Led, Online Self-Management Program for Adult Atopic Dermatitis: A Multi-center Randomized Controlled Trial
1个月前
已完结
Early Treatment for Multiple Sclerosis
1个月前
已完结
Multiple sclerosis
1个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
1个月前
已完结
Melatonin as an adjuvant treatment for atopic dermatitis
1个月前
已关闭
皖公网安备34019202002308
